Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic

American Journal of Pathology

Volumn 149, Issue 1, 1996, Pages 247-258

  Lingen, Mark W ^a,b   Polverini, Peter J ^c   Bouck, Noël P ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; ISOTRETINOIN; RETINOIC ACID;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RAT; SQUAMOUS CELL CARCINOMA;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COLONIC NEOPLASMS; CORNEA; ENDOTHELIUM, VASCULAR; FEMALE; FIBROSARCOMA; HUMANS; INTERLEUKIN-8; KERATINOCYTES; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTRALIZATION TESTS; PHENOTYPE; RATS; RATS, INBRED F344; TONGUE NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0029982831     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Lippman SM, Hong WK: Second malignant tumors in head and neck squamous cell carcinoma: the over-shadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989, 17:691-694
2. Chung KY, Mukhopadyay T, Kim J, Casson A, Ro J, Goepfert H, Hong WK, Roth JA: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993, 53:1676-1683
3. Nees M, Homann N, Discher H, Andl T, Enders C, Herold-Mende, Schuhmann A, Bosch FX: Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple primary tumors. Cancer Res 1993, 53:4189-4196
4. Zariwala M, Schmid S, Pflatz M, Ohgaki H, Kleihues P, Schafer R: p53 gene expression in oropharyngeal carcinomas of solitary and multiple primary tumors and lymph-node metastases. Int J Cancer 1994, 56:807-811
5. Slaughter DP, Southwick HW, Smejkal W: "Field cancerization" in oral stratified squamous epithelium. Cancer 1953, 6:963-968
6. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA, Sidransky D: Association between cigarette smoking and mutation of p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 1995, 332:712-717
7. Hong KW, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, Goepfert H: Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990, 323:795-801
8. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong KW: Comparison of low-dose isotretinoin with β carotene to prevent oral carcinogenesis. N Engl J Med 1993, 328:15-20
9. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper P, Strong S: 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986, 315:1501-1505
10. Meyskens, FL, Gilmartin E, Alberts DS, Levine NS, Brooks R, Salmon SE, Surwit EA: Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treat Rep 1982, 66:1315-1319
11. Gudas LJ: Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ 1992, 3:655-662
12. Amos B, Lotan R: Retinoid-sensitive cells and cell lines. Methods Enzymol 1990, 190:217-225
13. Zou CP, Clifford J, Xu XC, Sacks P, Chambon P, Hong, WK, Lotan R: Modulation by retinoic acid (RA) of squamous differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous carcinoma cell lines. Cancer Res 1994, 54:5479-5487
14. Shalinsky DR, Bischoff ED, Gregory ML, Gottardis MM, Hayes JS, Lamph WW, Heyman RA, Shirley MA, Cooke TA, Davies PJ, Thomazy V: Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Cancer Res 1995, 55:3183-3191
15. Smith MA, Parkinson DR, Cheson BD, Friedman MA: Retinoids in cancer therapy. J Clin Oncol 1992, 10: 839-864
16. Lotan R, Lotan D, Sacks PG: Inhibition of tumor cell growth by retinoids. Methods Enzymol 1990, 190:100-110
17. Sacks PG, Harris D, Chou TC: Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents. Int J Cancer 1995, 61:409-415
18. Folkman J: Tumor angiogenesis. The Molecular Basis of Cancer. Edited by J Mendelsohn, PM Howley, MA Israel, LA Liotta. Philadelphia, WB Saunders, 1995, pp 206-232
19. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1995, 79:315-328
20. Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases-balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995, 1:149-153
21. Oikawa T, Nakamura O, Shudo K, Hiragun A, Iwaguchi T: A highly potent antiangiogenic activity of retinoids. Cancer Lett 1989, 48:157-162
22. Ingber D, Folkman J: Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 1988, 59:44-51
23. Arensman RM, Stolar CH: Vitamin A effect on tumor angiogenesis. J Pediatr Surg 1979, 14:809-813
24. Rudnicka L, Marczak M, Szmurlo A, Makiela B, Skiendzielewska A, Skopinska M, Majewski S, Jablonska S: Acitretin decreases tumor cell-induced angiogenesis. Skin Pharmacol 1991, 4:150-153
25. Majewski S, Szmurlo A, Marczak M, Jablonska S, Bollag W: Inhibition of tumor cell-induced angiogenesis by retinoids, 1-25-dihydroxyvitamin D3 and their combination. Cancer Lett 1993, 75:35-39
26. Majewski S, Szmurlo A, Marczak M, Jablonska S, Bollag W: Synergistic effect of retinoids and interferon-α on tumor-induced angiogenesis: anti-angiogenic effect on hpv-harboring tumor-cell lines. Int J Cancer 1994, 57:81-85
27. Majewski S, Marczak M, Szmurlo A, Jablonska S, Bollag W: Retinoids interferon-α, 1,25-dihydroxyvitamin D3, and their combination inhibit angiogenesis induced by non-hpv-harboring tumor cell lines: RAR-α mediates the antiangiogenic effects of retinoids. Cancer Lett 1995, 89:117-124
28. Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Messetti M, Testolin A, Bevilacqua P: Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 1993, 55:739-744
29. Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ: Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 1994, 168:373-380
30. Petruzzelli GJ, Snyderman CH, Johnson JT, Myers EN: Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embryo chorioallantoic membrane model. Ann Otol Rhinol Laryngol 1993, 102:215-221
31. Rheinwald JG, Beckett MA: Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 1981, 41:1657-1663
32. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988, 106:761-771
33. Polverini PJ, Bouck NP, Rastinejad F: Assay and purification of naturally occurring inhibitor of angiogenesis. Methods Enzymol 1991, 198:440-450
34. Bouck N, Stellmach V, Hsu S: How tumors become angiogenic. Adv Cancer Res 1996 (in press)
35. Kato M, Ishizaki A, Hellman U, Wernstedt C, Kyogoku M, Miyazono K, Heldin CH, Funa K: A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium and cell density dependent manner. J Biol Chem 1995, 270:12373-12379
36. Mohanadzadeh M, Muller M, Hultsch T, Enk A, Saloga J, Knop J: Enhanced expression of IL-8 in normal human keratinocytes and human keratinocyte cell line HaCat in vitro after stimulation with contact sensitizers, tolerogens, and irritants. Exp Dermatol 1994, 3:298-303
37. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S: Regulation of vascular endothelial cell growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995, 270:12607-12613
38. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1803
39. Schreiber AB, Winkler ME, Derynck R: Transforming growth factor-α a more potent angiogenic mediator than epidermal growth factor. Science 1986, 232: 1250-1253
40. Smith MA, Parkinson DR, Cheson BD, Friedman MA: Retinoids in cancer therapy. J Clin Oncol 1992, 10: 839-864
41. Cohen RF, Contrino J, Spiro JD, Mann EA, Chen LL, Kreutzer DL: Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1995, 121:202-209
42. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM: Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994, 179:1409-1415
43. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994, 144:820-828
44. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986, 83:4167-4171
45. Yang EY, Moses HL: Transforming growth factor β1 induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1993, 111:731-741
46. Plouet J, Gospodarowicz D: Transforming growth factor β-1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells. J Cell Physiol 1989, 141:392-399
47. Myoken Y, Kan M, Sato GH, McKeehan WL, Sato JD: Bifunctional effects of transforming growth factor β (TGF-β) on endothelial cell growth correlates with phenotypes of TGF-β binding sites. Exp Cell Res 1990, 191:299-304
48. Pepper MS, Vassalli JD, Orci L, Montesano R: Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res 1993, 204:356-363
49. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derived from two separate domains of thrombospondin-1 have anti-angiogenic activity. J Cell Biol 1993, 122:497-511
50. Game SM, Stone A, Scully C, Prime SS: Tumor progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-β receptor expression and altered responses to these growth factors. Carcinogenesis 1990, 11:965-973
51. Missero C, Cajal SR, Dotto GP: Escape from transforming growth factor β control and oncogene cooperation in skin tumor development. Proc Natl Acad Sci USA 1991, 88:9613-9617
52. Reiss M, Munoz-Antonia T, Cowan JM, Wilkins PC, Zhou Z, Vellucci VF: Resistance of human squamous cell carcinoma cells to transforming growth factor β 1 is a recessive trait. Proc Natl Acad Sci USA 1993, 90:6280-6284
53. Schultz-Hector S, Haghayegh S: B-Fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res 1993, 53:1444-1449
54. Janot F, Elnaggar AK, Morrison RS, Liu TJ, Taylor DL, Clayman GL: Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 1995, 64:117-123
55. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990, 87:6624-6628
56. Dameron KM, Volpert OV, Tainsky MA, Bouck N: Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994, 265: 1582-1584
57. Dameron KM, Volpert OV, Tainsky MA, Bouck N: The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin. Cold Spring Harbor Symp Quant Biol 1994, LVIX:1-7
58. Morocco JR, Solt DB, Polverini PJ: Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. Lab Invest 1990, 63:298-306
59. Varani J, Gibbs DF, Inman DR, Shah B, Fligiel SEG, Vorhees JJ: Inhibition of epithelial cell adhesion by retinoic acid. Am J Pathol 1991, 138:887-895
60. Ligen MW, Polverini PJ, Bouck NP: Inhibition of squamous cell carcinoma angiogenesis by direct action of retinoic acid with endothelial cells. Lab Invest 1996, 74:476-483